Menu

ALEC, a conservative legislative group that receives drug industry funding, is advocating against state 340B legislation. Provider groups have criticized the campaign and launched their own efforts in support of 340B state bills.

340B Program Critics, Supporters Target States

May 2, 2024 Shannon Young, Associate Editor/Senior Writer 340B Report Views

As 340B stakeholders continue to hold out for long-awaited congressional action that could overhaul the discount drug pricing program, some [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Group Critical of Medicare Negotiation and 340B Program Suggests 340B Providers May Avoid IRA Negotiated Lower-Cost Drugs

Federal Bill Introduced to Expand 340B Eligibility to Outpatient-Focused Rural Emergency Hospitals